Susquehanna International Group
MIST icon

Susquehanna International Group’s Milestone Pharmaceuticals MIST Stock Holding History

Susquehanna International Group’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$618K Sell
519,046
-124,254
-19% -$218K ﹤0.01% 9111
2025
Q4 		$1.3M Buy
643,300
+386,528
+151% +$833K ﹤0.01% 6586
2025
Q3 		$514K Buy
256,772
+193,403
+305% +$340K ﹤0.01% 8886
2025
Q2 		$123K Buy
63,369
+1,309
+2% +$1.75K ﹤0.01% 11661
2025
Q1 		$49.7K Buy
62,060
+28,968
+88% +$57.6K ﹤0.01% 11865
2024
Q4 		$78.1K Buy
+33,092
New +$56.8K ﹤0.01% 11481
2024
Q1 		– Sell
-13,299
Closed -$22.2K – 12882
2023
Q4 		$22.2K Buy
+13,299
New +$36.1K ﹤0.01% 11953
2023
Q3 		– Sell
-23,261
Closed -$66.3K – 12586
2023
Q2 		$66.3K Buy
23,261
+10,875
+88% +$41K ﹤0.01% 11209
2023
Q1 		$48.8K Buy
+12,386
New +$45.3K ﹤0.01% 11706
2022
Q4 		– Sell
-46,308
Closed -$244K – 13183
2022
Q3 		$426K Buy
46,308
+28,075
+154% +$213K ﹤0.01% 8895
2022
Q2 		$108K Buy
+18,233
New +$112K ﹤0.01% 11404
2021
Q1 		– Sell
-10,144
Closed -$74.2K – 12601
2020
Q4 		$68K Buy
+10,144
New +$67.9K ﹤0.01% 10661

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Susquehanna International Group's MIST Position: Q1 2026 in Review

Susquehanna International Group reduced its Milestone Pharmaceuticals (MIST) stake by 19% in Q1 2026, selling an estimated $218K and leaving 519,046 shares worth $618K. The position accounts for ﹤0.01% of the portfolio, ranked #9111.

Susquehanna International Group first reported a position in MIST in Q4 2020 and has held it in 12 quarters since. The position peaked at $1.3M in Q4 2025. 86 funds tracked by Wall St. Rank hold MIST as of Q1 2026.

  • Susquehanna International Group held 519,046 shares of Milestone Pharmaceuticals worth $618K as of Q1 2026.
  • Susquehanna International Group sold 124,254 Milestone Pharmaceuticals shares in Q1 2026, an estimated $218K.
  • Milestone Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #9111 holding.
  • Susquehanna International Group first reported a position in Milestone Pharmaceuticals in Q4 2020 and has held it in 12 quarters since.
  • Susquehanna International Group's Milestone Pharmaceuticals position peaked at $1.3M in Q4 2025.
  • 86 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.